Key statistics
On Tuesday, Pacira Biosciences Inc (PCRX:NSQ) closed at 15.66, 40.27% above the 52 week low of 11.16 set on Aug 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.90 |
---|---|
High | 16.11 |
Low | 15.64 |
Bid | 15.30 |
Offer | 16.07 |
Previous close | 15.99 |
Average volume | 786.16k |
---|---|
Shares outstanding | 46.13m |
Free float | 45.19m |
P/E (TTM) | 13.67 |
Market cap | 737.57m USD |
EPS (TTM) | 1.17 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
- Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
- Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey
- Pacira BioSciences Reports Second Quarter 2024 Financial Results
- Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024
- Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
- Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
- Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
- Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
More ▼